Page 50 - GPD-3-3
P. 50

Gene & Protein in Disease                                         Phage therapy for Mycobacterium infections



               doi: 10.1186/s12866-017-1131-2                     CRB2  defines  a  new subcluster  in  mycobacteriophage
                                                                  classification. PLoS One. 2019;14(2):e0212365.
            14.  Halleran A, Clamons S, Saha M. Transcriptomic
               characterization of an infection of Mycobacterium smegmatis      doi: 10.1371/journal.pone.0212365
               by the Cluster A4 mycobacteriophage kampy.  PLoS One.   25.  Yue X, Huang Y, Zhang Y, Ouyang H, Xie J, Fu Z.
               2015;10(10):e0141100.
                                                                  Mycobacteriophage  SWU1-Functionalized  magnetic
               doi: 10.1371/journal.pone.0141100                  particles for facile bioluminescent detection of Mycobacterium
                                                                  smegmatis. Anal Chim Acta. 2021;1145:17-25.
            15.  Fan X, Duan X, Tong Y,  et al. The global reciprocal
               reprogramming between mycobacteriophage SWU1  and      doi: 10.1016/j.aca.2020.12.009
               Mycobacterium reveals the molecular strategy of subversion   26.  Ford ME, Stenstrom C, Hendrix RW, Hatfull GF.
               and promotion of phage infection. Front Microbiol. 2016;7:41.
                                                                  Mycobacteriophage TM4: Genome structure and gene
               doi: 10.3389/fmicb.2016.00041                      expression. Tuber Lung Dis. 1998;79(2):63-73.
            16.  Dedrick RM, Marinelli LJ, Newton GL, Pogliano  K,      doi: 10.1054/tuld.1998.0007
               Pogliano J, Hatfull GF. Functional requirements for   27.  Hatfull GF, Pedulla ML, Jacobs-Sera D, et al. Exploring the
               bacteriophage growth: Gene essentiality and expression in   mycobacteriophage  metaproteome:  Phage  genomics  as  an
               mycobacteriophage Giles. Mol Microbiol. 2013;88(3):577-589.
                                                                  educational platform. PLoS Genet. 2006;2(6):e92.
               doi: 10.1111/mmi.12210
                                                                  doi: 10.1371/journal.pgen.0020092
            17.  Ko CC, Hatfull GF. Mycobacteriophage Fruitloop gp52   28.  Bowman BU, Newman HA, Moritz JM, Koehler RM.
               inactivates Wag31 (DivIVA) to prevent heterotypic   Properties of mycobacteriophage DS6A. II. Lipid
               superinfection. Mol Microbiol. 2018;108(4):443-460.
                                                                  composition. Am Rev Respir Dis. 1973;107(1):42-49.
               doi: 10.1111/mmi.13946
                                                                  doi: 10.1164/arrd.1973.107.1.42
            18.  Dedrick RM, Jacobs-Sera D, Bustamante CA,  et al.   29.  Mayer O, Jain P, Weisbrod TR, et al. Fluorescent reporter
               Prophage-mediated defence against viral attack and viral   DS6A mycobacteriophages reveal unique variations
               counter-defence. Nat Microbiol. 2017;2:16251.
                                                                  in infectibility and phage production in mycobacteria.
               doi: 10.1038/nmicrobiol.2016.251                   J Bacteriol. 2016;198(23):3220-3232.
            19.  Hatfull GF, Cresawn SG, Hendrix RW. Comparative genomics      doi: 10.1128/jb.00592-16
               of the mycobacteriophages: Insights into bacteriophage   30.  Zalewska-Piątek B. Phage Therapy-challenges, opportunities
               evolution. Res Microbiol. 2008;159(5):332-339.
                                                                  and future prospects.  Pharmaceuticals  (Basel). 2023;
               doi: 10.1016/j.resmic.2008.04.008                  16(12):1638.
            20.  Fullner KJ, Hatfull GF. Mycobacteriophage L5 infection      doi: 10.3390/ph16121638
               of  Mycobacterium bovis BCG: Implications for phage   31.  Pérez-Sánchez  T,  Mora-Sánchez  B,  Balcázar  JL.
               genetics in the slow-growing mycobacteria. Mol Microbiol.   Biological approaches for disease control in aquaculture:
               1997;26(4):755-766.
                                                                  Advantages, limitations and challenges.  Trends  Microbiol.
               doi: 10.1046/j.1365-2958.1997.6111984.x            2018;26(11):896-903.
            21.  Ford ME, Sarkis GJ, Belanger AE, Hendrix RW, Hatfull GF.      doi: 10.1016/j.tim.2018.05.002
               Genome structure of mycobacteriophage D29: Implications   32.  Mahdavi SZB, Oroojalian F, Eyvazi S,  et al. An overview
               for phage evolution. J Mol Biol. 1998;279(1):143-164.
                                                                  on display systems (phage, bacterial, and yeast display)
               doi: 10.1006/jmbi.1997.1610                        for production of anticancer antibodies; Advantages and
                                                                  disadvantages. Int J Biol Macromol. 2022;208:421-442.
            22.  Sampson T, Broussard GW, Marinelli LJ,  et al.
               Mycobacteriophages BPs, Angel and Halo: Comparative      doi: 10.1016/j.ijbiomac.2022.03.113
               genomics reveals a novel class of ultra-small mobile genetic   33.  Anyaegbunam NJ, Anekpo CC, Anyaegbunam ZKG,
               elements. Microbiology (Reading). 2009;155(Pt 9):2962-2977.
                                                                  et al. The resurgence of phage-based therapy in the era of
               doi: 10.1099/mic.0.030486-0                        increasing antibiotic resistance: From research progress to
                                                                  challenges and prospects. Microbiol Res. 2022;264:127155.
            23.  Dedrick RM, Guerrero Bustamante CA, Garlena RA,
               Pinches RS, Cornely K, Hatfull GF. Mycobacteriophage ZoeJ:      doi: 10.1016/j.micres.2022.127155
               A  broad host-range close relative of mycobacteriophage   34.  Kasman LM, Porter LD. Bacteriophages. In:  StatPearls.
               TM4. Tuberculosis (Edinb). 2019;115:14-23.
                                                                  Treasure Island, FL: StatPearls Publishing LLC; 2024.
               doi: 10.1016/j.tube.2019.01.002
                                                               35.  Hatfull GF. Actinobacteriophages: Genomics, dynamics,
            24.  Suarez CA, Franceschelli JJ, Morbidoni HR. Mycobacteriophage   and applications. Annu Rev Virol. 2020;7(1):37-61.


            Volume 3 Issue 3 (2024)                         11                              doi: 10.36922/gpd.2935
   45   46   47   48   49   50   51   52   53   54   55